The ICH Q9 revision clarifies QRM implementation for the pharmaceutical industry and expands descriptions of methodology, formality, and risk-based decision making to provide the industry with a solid ...
This paper reflects upon the past 15 years of experience in the application of QRM and KM within the pharmaceutical GMP environment. It is important to understand the differences between risk-based ...
Experts have recommended ICH Q10 PQS (International Council for Harmonisation - Pharmaceutical Quality System) guidelines on pharma quality systems for effective implementation of revised Schedule M ...
This one day course provides the delegate with understanding of the principles of and practical application of Quality Risk Management (QRM). The course is focused on ICH Q9 (QRM) requirements and its ...
(MENAFN- GlobeNewsWire - Nasdaq) Stay informed on ICH Q9R1 Quality Risk Management updates and their practical implications for pharmaceutical manufacturing. Learn the latest Q9R1 requirements, ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Risk Management - ICH E6(R3) and FDA Expectations (Sept 5, 2025)" training has been added to ResearchAndMarkets.com's offering .This ...
Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.
The internationally harmonized guideline for a risk-based approach on assessing and controlling elemental impurities in drug products entered the final implementation phase. ICH Q3D(R1) Guideline for ...
Editor's Note: "Rebalancing Quality Priorities" is a three-part series describing a new approach to quality management from a customer and risk management perspective that involves the entire ...
Environmental contamination control is a crucial aspect of sterile pharmaceutical manufacturing, and risk management is needed to guarantee that the necessary control procedures are in place. The risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results